Article of: Slava
Map
Eur J Obstet Gynecol Reprod Biol. 2007;130(1):140-1.
“DT56a has anti-estrogenic properties in the breast tissue…”
20.07.2016
17:49
Comments Off on Eur J Obstet Gynecol Reprod Biol. 2007;130(1):140-1.
Slava
Read More »
Clin. and Exp. Ob. & Gyne. 2004;31(2):123-6.
“significant reduction in the Kupperman index following 12 weeks of treatment, which was sustained throughout the 12 months of treatment”
Menopause. 2003;10(6):522-5.
“Femarelle treatment in postmenopausal women increases BMD without unwanted estrogenic effect.”
J Steroid Biochem Mol Biol.. 2006;98(1):90-6
“DT56a.. unique nature compared to the compounds currently used for postmenopausal osteoporosis by being bone-forming and not only an anti-resorptive
Climacteric. 2015;18(6):813-6
“Treatment with DT56a resulted in a significant reduction of hot flushes in postmenopausal women… observed within the first month of treatment.”
BJOG. 2005;112(7):981-5
“DT56a prevents postmenopausal osteoporosis.”
Menopause 2011;18(3):285-288
“Femarelle … inhibits menopausal symptoms without thrombogenicity…”
NAMS Annual Congress 2011, book of abstracts
” DT56a was effective against symptomatic vulvo-vaginal atrophy (vaginal dryness)…”
J Endocrinol Invest. 36(7):521-6
“DT56a decreased menopausal symptoms significantly and in the same degree as HT.”